A medical breakthrough - IceSense - Treatment of tumors
On Clinic signed a contract with IceCure, a company engaged in development of minimally invasive, innovative office-based medical equipment for treatment of tumors that occurs in the female breast, using Cryoablation, a technology that freezes the tumors.
According to the contract, On Clinic shall act as an exclusive distributor of IceSense3 in Russia, Romania, Ukraine and Bulgaria.
IceSense system delivers the promise of rapid, office-based Cryoablation for the definitive treatment of fibroadenoma.
Cryoablation for fibroadenoma has the advantage of being an office-based procedure with no need for systematic anesthesia, minimal discomfort and what is most important for women - little to no scarring.
The FDA has approved the use of Cryoablation as a safe and effective therapy for fibroadenomas. Results of Cryoablation have been followed out to 4 years and demonstrate the procedure to be safe, efficacious and durable.
Cryoablation for fibroadenoma represents an attractive alternative for both the physician and the woman patient.